Table 1 Demographic and Clinical characteristics
Age (years) mean ± SD | 10.6 ± 5.1 |
|---|---|
Gender: # female/male | 23/7 |
JIA Subtype n(%) | Polyarticular 18 (60%) |
Oligoarticular 12 (40%) | |
Disease duration (years) mean ± SD | 5.4 + 1.9 |
Painful joint count mean ± SD | 4.9 ± 1.7 |
Swollen joint count mean ± SD | 3.5 ± 1.8 |
Limited joint count mean ± SD | 1.9 ± 0.9 |
Joints clinically affected n (%) | |
Wrist | 17 (28) |
MCP 2 | 14 (23) |
MCP 3 | 10 (17) |
ESR mm/hr mean ± SD | 17.5 ± 14.2 |
CRP mg/L mean ± SD | 15 ± 0.7 |
Positive Rheumatoid factor number (%) | 14 (43%) |
Positive Antinuclear antibodies number (%) | 19 (57%) |
Treatment n (%) | Methotrexate 28 (86%) Sulfasalazine 10 (30%) Biologic therapy 6 (20%) Prednisone 5 (16%) |